IA
CRBU icon

IFP Advisors’s Caribou Biosciences CRBU Stock Holding History

IFP Advisors’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1
Closed -$2 – 5047
2025
Q4 		$2 Sell
1
-26
-96% -$55 ﹤0.01% 4870
2025
Q3 		$63 Sell
27
-118
-81% -$223 ﹤0.01% 4618
2025
Q2 		$183 Buy
145
+104
+254% +$102 ﹤0.01% 4647
2025
Q1 		$37 Hold
41
– – ﹤0.01% 4077
2024
Q4 		$65 Buy
+41
New +$82 ﹤0.01% 4173

Other funds holding CRBU

P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

IFP Advisors's CRBU Position: Q1 2026 in Review

IFP Advisors sold out of Caribou Biosciences (CRBU) in Q1 2026, closing a stake of 1 share — an estimated $2 sold.

IFP Advisors first reported a position in CRBU in Q4 2024 and held it in 5 quarters. The position peaked at $183 in Q2 2025. 137 funds tracked by Wall St. Rank hold CRBU as of Q1 2026.

  • IFP Advisors reported no remaining Caribou Biosciences position as of Q1 2026 after selling out during the quarter.
  • IFP Advisors sold 1 Caribou Biosciences share in Q1 2026, an estimated $2.
  • IFP Advisors first reported a position in Caribou Biosciences in Q4 2024 and held it in 5 quarters.
  • IFP Advisors's Caribou Biosciences position peaked at $183 in Q2 2025.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q1 2026.

Based on IFP Advisors's 13F filing for Q1 2026, filed 13 Apr 2026.